Salicylanilide carbamates: Antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 3, 2010, Pages 1054-1061

  Férriz, Juana M ^a   Vávrová, Kateřina ^a   Kunc, Filip ^b,c   Imramovský, Aleš ^d   Stolaříková, Jiřina ^e   Vavříková, Eva ^a   Vinšová, Jarmila ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c GENERI BIOTECH sro   (Czech Republic)

^d UNIVERSITY OF PARDUBICE   (Czech Republic)

^e Health Institute in Ostrava   (Czech Republic)

Author keywords

Chemical hydrolysis; Cytotoxicity; In vitro antimycobacterial activity; Multidrug resistant tuberculosis; Salicylanilide carbamates

Indexed keywords

4 CHLORO 2 (3 CHLOROPHENYLCARBAMOYL)PHENYL OCTYLCARBAMATE; 4 CHLORO 2 (3 CHLOROPHENYLCARBAMOYL)PHENYL UNDECYLCARBAMATE; 4 CHLORO 2 (3 CHLOROPHENYLCARBAMOYL)PHENYLBUTYLCARBAMATE; 4 CHLORO 2 (3 CHLOROPHENYLCARBAMOYL)PHENYLDECYLCARBAMATE; 4 CHLORO 2 (3 CHLOROPHENYLCARBAMOYL)PHENYLETHYLCARBAMATE; 4 CHLORO 2 (3 CHLOROPHENYLCARBAMOYL)PHENYLHEPTYLCARBAMATE; 4 CHLORO 2 (3 CHLOROPHENYLCARBAMOYL)PHENYLHEXYLCARBAMATE; 4 CHLORO 2 (3 CHLOROPHENYLCARBAMOYL)PHENYLNONYLCARBAMATE; 4 CHLORO 2 (3 CHLOROPHENYLCARBAMOYL)PHENYLPENTYLCARBAMATE; 4 CHLORO 2 (3,4 DICHLOROPHENYLCARBAMOYL)PHENYL OCTYLCARBAMATE; 4 CHLORO 2 (3,4 DICHLOROPHENYLCARBAMOYL)PHENYL UNDECYLCARBAMATE; 4 CHLORO 2 (3,4 DICHLOROPHENYLCARBAMOYL)PHENYLBUTYLCARBAMATE; 4 CHLORO 2 (3,4 DICHLOROPHENYLCARBAMOYL)PHENYLDECYLCARBAMATE; 4 CHLORO 2 (3,4 DICHLOROPHENYLCARBAMOYL)PHENYLETHYLCARBAMATE; 4 CHLORO 2 (3,4 DICHLOROPHENYLCARBAMOYL)PHENYLHEPTYLCARBAMATE; 4 CHLORO 2 (3,4 DICHLOROPHENYLCARBAMOYL)PHENYLHEXYLCARBAMATE; 4 CHLORO 2 (3,4 DICHLOROPHENYLCARBAMOYL)PHENYLNONYLCARBAMATE; 4 CHLORO 2 (3,4 DICHLOROPHENYLCARBAMOYL)PHENYLPENTYLCARBAMATE; 4 CHLORO 2 (4 CHLOROPHENYLCARBAMOYL)PHENYL ETHYLCARBAMATE; 4 CHLORO 2 (4 CHLOROPHENYLCARBAMOYL)PHENYL NONYLCARBAMATE; 4 CHLORO 2 (4 CHLOROPHENYLCARBAMOYL)PHENYL OCTYLCARBAMATE; 4 CHLORO 2 (4 CHLOROPHENYLCARBAMOYL)PHENYLBUTYLCARBAMATE; 4 CHLORO 2 (4 CHLOROPHENYLCARBAMOYL)PHENYLDECYLCARBAMATE; 4 CHLORO 2 (4 CHLOROPHENYLCARBAMOYL)PHENYLHEPTYLCARBAMATE; 4 CHLORO 2 (4 CHLOROPHENYLCARBAMOYL)PHENYLHEXYLCARBAMATE; 4 CHLORO 2 (4 CHLOROPHENYLCARBAMOYL)PHENYLPENTYLCARBAMATE; CARBAMIC ACID DERIVATIVE; SALICYLANILIDE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG HALF LIFE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE CELL; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PH; SCREENING;

ANTITUBERCULAR AGENTS; CARBAMATES; CELL LINE; CELL PROLIFERATION; HUMANS; MYCOBACTERIUM TUBERCULOSIS; SALICYLANILIDES; TUBERCULOSIS;

MYCOBACTERIUM AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS;

EID: 75149117787     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.12.055     Document Type: Article

References (37)

1. Espinal M.A. Tuberculosis (Edinb) 83 (2003) 44
2. Shenoi S., and Friedland G. Annu. Rev. Med. 60 (2009) 307
3. http://www.who.int/tb/en/.
4. Janin Y.L. Bioorg. Med. Chem. 15 (2007) 2479
5. Dye C.F.K., Gunneberg C., Hosseini M., Lonnroth K., Nathanson E., Pantoky A., Piatek M., Uplekar M., Watt C., Williams B., and Wright A. Zignol. 1st. ed. (2007), World Health Organization, Geneva
6. http://www.who.int/tb/publications/2008/factsheet_april08.pdf.
7. Breen R.A., Swaden L., Ballinger J., and Lipman M.C. Drugs 66 (2006) 2299
8. Zhang Y., Post-Martens K., and Denkin S. Drug Discovery Today 11 (2006) 21
9. Brown E.D., and Wright G.D. Chem. Rev. 105 (2005) 759
10. Vinsova J., and Imramovsky A. Ceska Slov. Farm. 53 (2004) 294
11. De la Fuente R., Sonawane N.D., Arumainayagam D., and Verkman A.S. Br. J. Pharmacol. 149 (2006) 551
12. Dahlgren M.K., Kauppi A.M., Olsson I.M., Linusson A., and Elofsson M. J. Med. Chem. 50 (2007) 6177
13. Vinsova J., Imramovsky A., Buchta V., Ceckova M., Dolezal M., Staud F., Jampilek J., and Kaustova J. Molecules 12 (2007) 1
14. Daidone G., Raffa D., Plescia S., Matera M., Caruso A., Leone V., and Amico-Roxas M. Farmaco 44 (1989) 465
15. Waisser K., Matyk J., Divisova H., Husakova P., Kunes J., Klimesova V., Kaustova J., Mollmann U., Dahse H.M., and Miko M. Arch. Pharm. (Weinheim) 339 (2006) 616
16. Stephenson K., Yamaguchi Y., and Hoch J.A. J. Biol. Chem. 275 (2000) 38900
17. Macielag M.J., Demers J.P., Fraga-Spano S.A., Hlasta D.J., Johnson S.G., Kanojia R.M., Russell R.K., Sui Z., Weidner-Wells M.A., Werblood H., Foleno B.D., Goldschmidt R.M., Loeloff M.J., Webb G.C., and Barrett J.F. J. Med. Chem. 41 (1998) 2939
18. Kamath S., and Buolamwini J.K. Med. Res. Rev. 26 (2006) 569
19. Brown M.E., Fitzner J.N., Stevens T., Chin W., Wright C.D., and Boyce J.P. Bioorg. Med. Chem. 16 (2008) 8760
20. Boyce J.P., Brown M.E., Chin W., Fitzner J.N., Paxton R.J., Shen M., Stevens T., Wolfson M.F., and Wright C.D. Bioconjugate Chem. 19 (2008) 1775
21. Ray S., Pathak S.R., and Chaturvedi D. Drugs Future 30 (2005) 161
22. Agouridas C., Denis A., Auger J.M., Benedetti Y., Bonnefoy A., Bretin F., Chantot J.F., Dussarat A., Fromentin C., D'Ambrieres S.G., Lachaud S., Laurin P., Le Martret O., Loyau V., and Tessot N. J. Med. Chem. 41 (1998) 4080
23. Meng Q., Luo H., Liu Y., Li W., Zhang W., and Yao Q. Bioorg. Med. Chem. 19 (2009) 2908
24. Thorberg S., Berg S., Lundstrom L., Pettersson B., Wijkstrom A., Sanchez D., Lindberg P., and Nilsson J.G. J. Med. Chem. 30 (1987) 2008
25. Waisser K., Bures O., Holy P., Kunes J., Oswald R., Jiraskova L., Pour M., Klimesova V., Kubicova L., and Kaustova J. Arch. Pharm. (Weinheim) 336 (2003) 53
26. Imramovsky A., Vinsova J., Ferriz J.M., Buchta V., and Jampilek J. Bioorg. Med. Chem. Lett. 19 (2009) 348
27. Imramovsky A., Vinsova J., Ferriz J.M., Dolezal R., Jampilek J., Kaustova J., and Kunc F. Bioorg. Med. Chem. 17 (2009) 3572
28. Lenaerts A.J., Gruppo V., Marietta K.S., Johnson C.M., Driscoll D.K., Tompkins N.M., Rose J.D., Reynolds R.C., and Orme I.M. Antimicrob. Agents Chemother. 49 (2005) 2294
29. Stover C.K., Warrener P., VanDevanter D.R., Sherman D.R., Arain T.M., Langhorne M.H., Anderson S.W., Towel J.A., Yuan Y., Mc Murray D.N., Kreiswirth B.N., Barry C.E., and Baker W.R. Nature 405 (2000) 962
30. Nikonenko B.V., Protopopova M., Sarnala R., Einck L., and Nacy C.A. Antimicrob. Agents Chemother. 51 (2007) 1563
31. Jia L., Tomaszewski J.E., Hanrahan C., Coward L., Noker P., Gorman G., Nikonenko B., and Protopopova M. Br. J. Pharmacol. 144 (2005) 80
32. Scudiero D.A., and Shoemaker R.H. Cancer Res. 48 (1988) 4827
33. http://www.taacf.org/Process-text.htm.
34. D'Souza A.J., and Topp E.M. J. Pharm. Sci. 93 (2004) 1962
35. Savolainen J., Leppanen J., Forsberg M., Taipale H., Nevalainen T., Huuskonen J., Gynther J., Mannisto P.T., and Jarvinen T. Life Sci. 67 (2000) 205
36. Dyer E., and Wright G.C. J. Am. Chem. Soc. 81 (1959) 2138
37. Beargie R.A., Bracken E.C., and Riley Jr. H.D. Appl. Microbiol. 13 (1965) 279